4164
承業醫
+0.30 (+1.19%)25.50271成交張數21.79本益比0.66股價淨值比4.35%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 162 | 75 | 51.4% | 1.70 | 38.25 | 3.1% | 1.4% | -0.9 | -2.7 |
| 2026Q1 | 160 | 74 | 50.6% | 1.78 | 38.13 | 2.9% | 1.3% | -2.2 | -3.6 |
| 2025Q4 | 156 | 76 | 48.5% | 1.87 | 39.06 | 2.7% | 1.3% | 5.1 | 3.2 |
| 2025Q3 | 148 | 76 | 46.4% | 2.17 | 38.72 | 2.3% | 1.1% | 2.4 | 1.8 |
| 2025Q2 | 152 | 70 | 51.5% | 1.74 | 37.92 | 2.8% | 1.3% | 1.0 | -2.4 |
| 2025Q1 | 145 | 69 | 50.0% | 1.55 | 37.30 | 2.7% | 1.2% | 1.5 | -1.3 |
| 2024Q4 | 142 | 63 | 53.1% | 1.36 | 37.77 | 2.6% | 1.2% | 3.2 | 2.5 |
| 2024Q3 | 135 | 63 | 51.2% | 1.52 | 37.69 | 5.2% | 2.4% | -1.7 | -3.0 |
| 2024Q2 | 137 | 62 | 51.8% | 2.58 | 37.14 | 4.5% | 2.0% | -1.6 | -2.0 |
| 2024Q1 | 138 | 62 | 52.9% | 2.36 | 36.92 | 5.6% | 2.5% | 1.1 | -0.7 |
| 2023Q4 | 136 | 65 | 50.2% | 3.04 | 38.81 | 6.7% | 3.2% | 6.8 | 6.3 |
| 2023Q3 | 133 | 62 | 50.5% | 2.52 | 37.63 | 4.9% | 2.4% | 2.3 | 0.9 |
| 2023Q2 | 134 | 61 | 51.6% | 2.37 | 37.24 | 5.9% | 2.8% | 2.1 | -0.4 |
| 2023Q1 | 134 | 60 | 52.7% | 2.17 | 36.66 | 6.3% | 2.9% | -1.6 | -2.7 |
| 2022Q4 | 128 | 61 | 50.1% | 3.65 | 38.02 | 5.8% | 2.8% | 2.0 | 0.9 |
| 2022Q3 | 125 | 61 | 49.3% | 2.95 | 37.53 | 6.9% | 3.4% | 2.8 | 0.6 |
| 2022Q2 | 128 | 60 | 51.4% | 2.32 | 36.86 | 6.3% | 3.1% | -0.1 | -2.2 |
| 2022Q1 | 125 | 58 | 51.2% | 2.43 | 36.22 | 5.7% | 2.8% | 1.8 | 0.4 |
| 2021Q4 | 126 | 61 | 49.8% | 2.55 | 37.78 | 6.4% | 3.2% | 4.2 | 3.2 |
| 2021Q3 | 116 | 58 | 49.1% | 2.91 | 36.73 | 5.2% | 2.4% | 0.9 | -0.7 |
| 2021Q2 | 117 | 60 | 47.8% | 3.30 | 38.29 | 6.9% | 3.3% | 0.4 | -1.6 |
| 2021Q1 | 117 | 59 | 47.7% | 3.18 | 37.88 | 7.2% | 3.5% | 1.5 | 0.9 |
| 2020Q4 | 115 | 58 | 48.0% | 3.31 | 37.23 | 6.7% | 3.2% | 6.2 | 2.8 |
| 2020Q3 | 127 | 56 | 54.7% | 2.45 | 36.93 | 7.4% | 3.4% | 1.0 | -0.4 |
| 2020Q2 | 114 | 50 | 54.4% | 1.29 | 35.47 | 7.9% | 3.5% | 0.2 | -0.5 |
| 2020Q1 | 112 | 52 | 51.9% | 1.16 | 36.83 | 7.9% | 3.7% | 1.7 | 0.1 |
| 2019Q4 | 112 | 52 | 52.5% | 1.15 | 36.45 | 7.8% | 3.6% | 7.6 | 6.4 |
| 2019Q3 | 108 | 51 | 51.6% | 1.71 | 35.93 | 8.0% | 3.7% | 1.8 | 1.3 |
| 2019Q2 | 112 | 49 | 54.7% | 1.49 | 34.93 | 7.1% | 3.1% | 2.1 | 1.6 |
| 2019Q1 | 111 | 50 | 52.9% | 1.72 | 36.01 | 7.4% | 3.4% | 0.3 | -0.9 |
| 2018Q4 | 108 | 50 | 52.7% | 2.37 | 35.54 | 6.5% | 3.0% | 0.9 | -0.1 |
| 2018Q3 | 108 | 49 | 53.9% | 1.44 | 35.04 | 0.8% | 0.4% | 1.6 | 1.2 |
| 2018Q2 | 109 | 49 | 55.0% | 1.50 | 34.75 | -0.8% | -0.4% | -0.3 | -2.1 |
| 2018Q1 | 104 | 49 | 52.8% | 1.61 | 35.03 | -2.9% | -1.4% | 1.8 | 1.3 |
| 2017Q4 | 106 | 49 | 53.6% | 1.69 | 35.12 | -1.8% | -0.9% | 1.3 | 0.5 |
| 2017Q3 | 103 | 48 | 53.0% | 0.95 | 34.42 | 5.0% | 2.4% | 1.8 | 1.1 |
| 2017Q2 | 103 | 49 | 52.8% | 1.06 | 34.72 | 4.8% | 2.3% | 0.0 | -0.4 |
| 2017Q1 | 97 | 50 | 48.8% | 1.12 | 35.63 | 4.5% | 2.3% | -0.2 | -0.7 |
| 2016Q4 | 98 | 50 | 49.2% | 1.14 | 35.52 | – | – | 6.4 | 4.5 |
| 2016Q3 | 95 | 48 | 49.2% | 2.57 | 34.44 | – | – | 1.1 | 0.7 |